153 related articles for article (PubMed ID: 12028464)
1. Predictors of renal function following lung or heart-lung transplantation.
Ishani A; Erturk S; Hertz MI; Matas AJ; Savik K; Rosenberg ME
Kidney Int; 2002 Jun; 61(6):2228-34. PubMed ID: 12028464
[TBL] [Abstract][Full Text] [Related]
2. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
4. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function.
Garrido IP; Crespo-Leiro MG; Paniagua MJ; Muñiz J; Vázquez-Rey E; Pérez-Fernández R; García-Lara J; Cuenca-Castillo JJ; Castro-Beiras A
J Heart Lung Transplant; 2005 Sep; 24(9):1226-30. PubMed ID: 16143237
[TBL] [Abstract][Full Text] [Related]
5. Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function.
Weir MR; Blahut S; Drachenburg C; Young C; Papademitriou J; Klassen DK; Cangro CB; Bartlett ST; Fink JC
Am J Nephrol; 2004; 24(4):379-86. PubMed ID: 15237243
[TBL] [Abstract][Full Text] [Related]
6. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
7. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
8. Predictors of decline in renal function after lung transplantation.
Barraclough K; Menahem SA; Bailey M; Thomson NM
J Heart Lung Transplant; 2006 Dec; 25(12):1431-5. PubMed ID: 17178337
[TBL] [Abstract][Full Text] [Related]
9. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
12. Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: results from the CAPRI study.
Delgado JF; Crespo-Leiro MG; Gómez-Sánchez MA; Paniagua MJ; González-Vílchez F; Vázquez de Prada JA; Fernández-Yáñez J; Pascual D; Almenar L; Martínez-Dolz L; Díaz B; Roig E; Segovia J; Arizón JM; Garrido I; Blasco T; López J; Brossa V; Manito N; Muñiz J
Clin Transplant; 2010; 24(5):E194-200. PubMed ID: 20597926
[TBL] [Abstract][Full Text] [Related]
13. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
Balfour IC; Srun SW; Wood EG; Belsha CW; Marshall DL; Ferdman BR
J Heart Lung Transplant; 2006 May; 25(5):518-22. PubMed ID: 16678029
[TBL] [Abstract][Full Text] [Related]
14. Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
Peddi VR; Kamath S; Munda R; Demmy AM; Alexander JW; First MR
Clin Transplant; 1998 Oct; 12(5):401-5. PubMed ID: 9787948
[TBL] [Abstract][Full Text] [Related]
15. Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression.
Groetzner J; Kaczmarek I; Mueller M; Huber S; Deutsch A; Daebritz S; Arbogast H; Meiser B; Reichart B
J Heart Lung Transplant; 2005 Nov; 24(11):1787-92. PubMed ID: 16297783
[TBL] [Abstract][Full Text] [Related]
16. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center.
Tinawi M; Miller L; Bastani B
Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic disorders in renal transplant recipients].
Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
[TBL] [Abstract][Full Text] [Related]
18. A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation.
Shuker N; Shuker L; van Rosmalen J; Roodnat JI; Borra LC; Weimar W; Hesselink DA; van Gelder T
Transpl Int; 2016 Nov; 29(11):1158-1167. PubMed ID: 27188932
[TBL] [Abstract][Full Text] [Related]
19. Rejection after simultaneous pancreas-kidney transplantation.
Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
[TBL] [Abstract][Full Text] [Related]
20. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
